TRANSCRIPT

Q3 2024 — Earnings call introductory remarks

Q3 2024PDF · 8 pages112 KB
CME Group 3Q 2024 Earnings Introductory Script
October 23, 2024
Adam Minick
Good morning, and I hope you are all doing well today. We released our
execuve commentary earlier this morning, which provides extensive
details on the third quarter 2024 which we will be discussing on this
call. I will start with the safe harbor language, then I’ll turn it over to
Terry.
Statements made on this call and in the other reference documents on
our website that are not historical facts are forward-looking statements.
These statements are not guarantees of future performance. They
involve risks, uncertaines and assumpons that are difficult to predict.
Therefore, actual outcomes and results may differ materially from what
is expressed or implied in any statement. Detailed informaon about
factors that may affect our performance can be found in the filings with
the SEC, which are on our website. Lastly, on the final page of the
earnings release, you will see a reconciliaon between GAAP and
non-GAAP measures.
With that, I’ll turn the call over to Terry.
1

-- 1 of 8 --

Terrence Duffy
Thanks Adam and thank you all for joining us this morning. I’m going to
make a few brief comments about the quarter and the overall
environment. Following that, Lynne will provide an overview of our
third-quarter financial results. In addion to Lynne, we have other
members of our management team present to answer quesons aer
the prepared remarks.
Our record-breaking performance in the third quarter demonstrated
the connued growing need for risk management globally. The third
quarter average daily volume of 28.3 million contracts was the highest
quarterly ADV in CME Group’s history and increased 27% compared to
the same period last year. This strong growth was broad-based, we
achieved year-over-year growth in both volume and open interest
across every asset class for the second consecuve quarter. In
aggregate, our financial products volume grew by 28% and our
commodies sector volumes grew by 20%.
This record volume was aided by the effecveness of our volume ers,
including the 36% year over year growth in our interest rate complex to
14.9 million contracts a day, with all me record volume levels for both
SOFR futures and Treasuries. We achieved this growth without
lowering any fees or introducing any new incenve programs for these
2

-- 2 of 8 --

products. The lower RPC was driven by increased trading volume and
our focus on ering allowed for incremental earnings growth given the
operang leverage in our model.
Our SOFR complex traded over 5.9 million contracts per day in the
quarter and 6.9 million per day in September, all while seeing the
customer network broaden with large open interest holders reaching a
new record high in September.
As you know, we oen hear the view that a rising Fed rate environment
is best for CME's interest rate volumes. However, over the last year,
there have been no Fed rate hikes and one rate cut, and our interest
rate complex grew 17% over the prior year which had 6 rate hikes
totaling 2.25%. Opposing views of potenal and actual Fed rate changes
combined with ongoing high levels of issuance and deficit financing
should connue to provide tailwinds for interest rates trading. The
uncertainty around the U.S. elecon and geopolical events around the
world also contribute to a growing need for liquid and efficient markets
to manage these risks in interest rates and across asset classes.
Q3 was also a record quarter for our internaonal business, where
average daily volume reached 8.4 million contracts, up 29% versus last
year. This was led by a record 6.2 million average daily volume from
EMEA, which was up 30%, and 1.9 million contracts per day in APAC, up
3

-- 3 of 8 --

28%. The record internaonal volume was driven by growth in all six
asset classes in both EMEA and APAC, with the highest volumes coming
from interest rate and equity products.
In addion to the impressive volume results, we delivered record
financial results for the second consecuve quarter. I’ll now turn the
call over to Lynne to review these results in more detail.
4

-- 4 of 8 --

Lynne Fitzpatrick
Thanks Terry and thank you all for joining us this morning. CME Group
set all me records for quarterly revenue, net income and earnings per
share in the second quarter this year and immediately surpassed each
of those records this quarter. Starng with the highest ever quarterly
revenue at nearly $1.6 billion, up 18% from the third-quarter in 2023.
Clearing and transacon fee revenue increased by 20% on our record
quarterly volume. Market data revenue of $178 million increased 6%
from the same quarter last year and Other Revenue increased 29% to
over $109 million.
Our strong cost discipline led to adjusted expenses of $489 million for
the quarter and $391 million, excluding license fees. The resulng
operang income of approximately $1.1 billion set a new quarterly
record. Our adjusted operang margin of 69.1% was up 260 basis
points from 66.5% in the same period last year. CME Group had an
adjusted effecve tax rate of 22.3%. Terry talked about the strength of
our Internaonal business. The strong growth coming from outside the
US has resulted in a lower effecve tax rate. We expect this trend to
connue in Q4 and we are lowering our tax rate guidance for the year
to a range of 22.5% to 23.0% as a result.
5

-- 5 of 8 --

Driven by the strong revenue growth and operang margin levels, we
delivered the highest quarterly adjusted net income and earnings per
share aributable to CME Group in our history at $977 million and
$2.68 per share, respecvely, both up 19% from the third quarter last
year. This represents an adjusted net income margin for the quarter of
61.7%.
Capital expenditures for the third quarter were approximately $30
million and cash at the end of the period was approximately $2.6
billion.
Our connued product innovaon, new customer acquision, and deep
liquid markets across the six major asset classes has led to a consistent,
higher, level of demand for our products. CME Group’s daily trading
volume surpassed 25 million contracts on 55% of the trading days in the
first three quarters of 2024, versus 35% of the days in the same period
of 2023. Also, each of the last six months were monthly volume records
helping us deliver our best quarterly financial results in Q2 which were
immediately surpassed by new records this quarter. We are very proud
of the team for their efforts to provide our clients with the technology
and products they need for risk management while driving earnings
growth for our shareholders.
We’d now like to open the call for your quesons. Thank you.
6

-- 6 of 8 --

Statements in this press release that are not historical facts are forward-looking statements. These statements are
not guarantees of future performance and involve risks, uncertaines and assumpons that are difficult to predict.
Therefore, actual outcomes and results may differ materially from what is expressed or implied in any
forward-looking statements. We want to cauon you not to place undue reliance on any forward-looking
statements. We undertake no obligaon to publicly update any forward-looking statements, whether as a result of
new informaon, future events or otherwise. Among the factors that might affect our performance are increasing
compeon by foreign and domesc enes, including increased compeon from new entrants into our markets
and consolidaon of exisng enes; our ability to keep pace with rapid technological developments, including our
ability to complete the development, implementaon and maintenance of the enhanced funconality required by
our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our
ability to connue introducing compeve new products and services on a mely, cost-effecve basis, including
through our electronic trading capabilies, and our ability to maintain the compeveness of our exisng products
and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain
exisng customers at substanally similar trading levels, develop strategic relaonships and aract new customers;
our ability to expand and globally offer our products and services; changes in regulaons, including the impact of
any changes in laws or government policies with respect to our products or services or our industry, such as any
changes to regulaons and policies that require increased financial and operaonal resources from us or our
customers; the costs associated with protecng our intellectual property rights and our ability to operate our
business without violang the intellectual property rights of others; decreases in revenue from our market data as a
result of decreased demand or changes to regulaons in various jurisdicons; changes in our rate per contract due
to shis in the mix of the products traded, the trading venue and the mix of customers (whether the customer
receives member or non-member fees or parcipates in one of our various incenve programs) and the impact of
our ered pricing structure; the ability of our credit and liquidity risk management pracces to adequately protect
us from the credit risks of clearing members and other counterpares, and to sasfy the margin and liquidity
requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk
management programs to effecvely monitor and manage our risks, including our ability to prevent errors and
misconduct and protect our infrastructure against security breaches and misappropriaon of our intellectual
property assets; our dependence on third-party providers and exposure to risk through third pares, including risks
related to the performance, reliability and security of technology used by our third-party providers and third-party
providers that our clients rely on; volality in commodity, equity and fixed income prices, and price volality of
financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign
exchange rates; economic, social, polical and market condions, including the volality of the capital and credit
markets and the impact of economic condions on the trading acvity of our current and potenal customers; our
ability to accommodate increases in contract volume and order messaging traffic and to implement enhancements
without failure or degradaon of the performance of our trading and clearing systems; our ability to execute our
7

-- 7 of 8 --

growth strategy and maintain our growth effecvely; our ability to manage the risks, control the costs and achieve
the synergies associated with our strategy for acquisions, investments and alliances, including those associated
with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and in
trade processing/post trade services (OSTTRA), our primary business and distribuon partners’ acons and our
partnership with Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds
for its clients; impact of CME Group pricing and incenve changes; impact of aggregaon services and
internalizaon on trade flow and volumes; any negave financial impacts from changes to the terms of intellectual
property and index rights; our ability to connue to generate funds and/or manage our indebtedness to allow us to
connue to invest in our business; industry, channel partner and customer consolidaon and/or concentraon;
decreases in trading and clearing acvity; the imposion of a transacon tax or user fee on futures and opons
transacons and/or repeal of the 60/40 tax treatment of such transacons; increases in effecve tax rates,
borrowing costs, or changes in tax policy; our ability to maintain our brand and reputaon; and the unfavorable
resoluon of material legal proceedings. For a detailed discussion and addional informaon concerning these and
other factors that might affect our performance, see our other recent periodic filings, including our Annual Report
on Form 10-K for the year ended December 31, 2023, as filed with the Securies and Exchange Commission ("SEC")
on February 28, 2024, under the capon "Risk Factors".
8

-- 8 of 8 --